renal cell carcinoma |
Disease ID | 28 |
---|---|
Disease | renal cell carcinoma |
Manually Symptom | UMLS | Name(Total Manually Symptoms:145) C2697391 | rheumatoid arthritis C2613439 | extramedullary hematopoiesis C2598155 | pain C2248595 | dedifferentiation C2173677 | renal cyst C2119038 | pleural metastasis C2073625 | pleural effusion C2039684 | systemic symptoms C1963185 | obesity C1962972 | proteinuria C1840264 | immune suppression C1839611 | n syndrome C1691228 | cystic disease of kidney C1609519 | adrenal myelolipoma C1608408 | malignant transformation C1550639 | fistula C1516669 | clonal evolution C1510885 | angiogenic switch C1415107 | stiff person syndrome C1335751 | inverted papilloma of the renal pelvis C1335745 | renal liposarcoma C1332900 | cerebellar hemangioblastoma C1332335 | arterial embolization C1321756 | achalasia C1306459 | primary malignant neoplasm C1142517 | lupus anticoagulant C1135207 | ataxia C1000587 | pemphigus C1000483 | anemia C0878650 | stauffer's syndrome C0878544 | cardiomyopathy C0854178 | adrenal metastases C0836924 | thrombocytosis C0741299 | atrial thrombus C0686619 | lymph node metastases C0684817 | neck metastasis C0684550 | spinal metastases C0555278 | cerebral metastases C0521607 | peritoneal fibrosis C0497156 | lymphadenopathy C0494165 | metastasis to liver C0494165 | liver metastasis C0494165 | liver metastases C0494165 | hepatic metastasis C0424755 | fever C0406650 | linear iga bullous dermatosis C0403416 | crescentic glomerulonephritis C0401040 | retroperitoneal fat necrosis C0398359 | trousseau's syndrome C0347005 | scrotal metastasis C0346993 | breast metastasis C0346993 | breast metastases C0346976 | pancreatic metastasis C0346255 | renal oncocytoma C0334121 | inflammatory myofibroblastic tumor C0333516 | tumor necrosis C0302148 | thrombus C0271901 | microcytic hypochromic anemia C0270612 | leukoencephalopathy C0268799 | acquired renal cystic disease C0268381 | primary amyloidosis C0268381 | al amyloidosis C0267373 | intestinal bleeding C0265050 | vena cava thrombosis C0240225 | hepatic mass C0238457 | renal vein thrombosis C0235782 | carcinoma of the gallbladder C0221002 | primary hyperparathyroidism C0220650 | brain metastasis C0220650 | brain metastases C0206667 | adrenocortical adenoma C0206667 | adrenal adenoma C0206635 | myelolipoma C0206633 | angiomyolipomas C0206180 | anaplastic large cell lymphoma C0155675 | pulmonary arteriovenous fistula C0153690 | osseous metastasis C0153690 | bony metastasis C0153690 | bone metastasis C0153690 | bone metastases C0153687 | skin metastasis C0153687 | skin metastases C0153687 | cutaneous metastasis C0153685 | renal metastasis C0153676 | pulmonary metastasis C0153676 | pulmonary metastases C0153676 | lung metastasis C0153676 | lung metastases C0152244 | aneurysmal bone cyst C0152002 | renal vasculitis C0151650 | renal fibrosis C0087086 | thrombi C0085652 | pyoderma gangrenosum C0085642 | livedo reticularis C0043092 | wegener's granulomatosis C0037933 | spine disease C0037928 | myelopathy C0037284 | skin lesions C0036527 | ovarian metastasis C0034902 | pure red cell aplasia C0034188 | xanthogranulomatous pyelonephritis C0034065 | pulmonary embolism C0031511 | adrenal pheochromocytoma C0030472 | paraneoplastic syndromes C0030472 | paraneoplastic syndrome C0029896 | ent disease C0027149 | myxoma C0027123 | myospherulosis C0027066 | myoclonus C0025470 | mesenteric lipodystrophy C0024232 | lymphatic metastases C0023903 | liver tumor C0023895 | liver disorder C0022681 | medullary sponge kidney C0022679 | cystic kidneys C0022665 | renal tumors C0022660 | acute renal failure C0022658 | nephropathy C0022079 | iris tumor C0021308 | infarction C0021053 | immune dysfunction C0020615 | hypoglycemia C0020546 | hypertensive crisis C0020456 | hyperglycemia C0020437 | hypercalcemia C0020437 | hypercalcaemia C0019562 | von hippel-lindau disease C0019562 | von hippel lindau disease C0019080 | hemorrhage C0018801 | heart failure C0017665 | membranous nephropathy C0017665 | membranous glomerulonephritis C0017661 | iga nephropathy C0017661 | iga glomerulonephritis C0014743 | erythema nodosum C0014130 | endocrinopathy C0013930 | tumor embolism C0013292 | duodenal obstruction C0009062 | clostridial infection C0008497 | choriocarcinoma C0007758 | cerebellar ataxia C0007138 | transitional cell carcinoma C0006625 | cachexia C0002736 | amyotrophic lateral sclerosis C0002726 | amyloidosis |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:51) C0040053 | thrombus | 46 C0153690 | bone metastasis | 12 C0028754 | obesity | 10 C0153690 | bone metastases | 8 C0153676 | lung metastases | 7 C0019562 | von hippel-lindau disease | 7 C0153676 | pulmonary metastasis | 6 C0002793 | dedifferentiation | 6 C0153676 | lung metastasis | 6 C0220650 | brain metastases | 5 C1332335 | arterial embolization | 4 C0220650 | brain metastasis | 4 C0018801 | heart failure | 3 C0019562 | von hippel lindau disease | 3 C0022665 | renal tumors | 3 C0153676 | pulmonary metastases | 3 C0153687 | cutaneous metastasis | 3 C0836924 | thrombocytosis | 3 C0153685 | renal metastasis | 3 C2119038 | pleural metastasis | 2 C0494165 | liver metastases | 2 C0016169 | fistula | 2 C0686619 | lymph node metastases | 2 C0155776 | renal vein thrombosis | 2 C0030193 | pain | 2 C0854178 | adrenal metastases | 2 C0030472 | paraneoplastic syndrome | 2 C0018952 | extramedullary hematopoiesis | 1 C0741299 | atrial thrombus | 1 C0023903 | liver tumor | 1 C0085652 | pyoderma gangrenosum | 1 C0022679 | renal cyst | 1 C0019080 | hemorrhage | 1 C0032227 | pleural effusion | 1 C0020437 | hypercalcemia | 1 C0034065 | pulmonary embolism | 1 C0003873 | rheumatoid arthritis | 1 C0027149 | myxoma | 1 C0521607 | peritoneal fibrosis | 1 C0268799 | acquired renal cystic disease | 1 C0346255 | renal oncocytoma | 1 C0346976 | pancreatic metastasis | 1 C0333516 | tumor necrosis | 1 C1335745 | renal liposarcoma | 1 C1609519 | adrenal myelolipoma | 1 C0153687 | skin metastasis | 1 C0494165 | liver metastasis | 1 C0002871 | anemia | 1 C0015967 | fever | 1 C0267373 | intestinal bleeding | 1 C0206635 | myelolipoma | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:90) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs10054504 | 23184150 | 23037 | PDZD2 | umls:C0007134 | GWASCAT | Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. | 0.120271442 | 2013 | PDZD2 | 5 | 32000377 | T | C |
rs1042522 | 17634539 | 7157 | TP53 | umls:C0007134 | BeFree | Polymorphisms of p53 Arg(72)Pro and p21 Ser(31)Arg did not show significant association with RCC. | 0.150355339 | 2007 | TP53 | 17 | 7676154 | G | T,C |
rs1045642 | 22358302 | 5243 | ABCB1 | umls:C1378703 | BeFree | In summary, this meta-analysis suggests that the MDR1 C3435T polymorphism is associated with cancer susceptibility, increasing the risk of breast and renal cancer. | 0.001900093 | 2012 | ABCB1 | 7 | 87509329 | A | T,G |
rs1049380 | 23911636 | 3709 | ITPR2 | umls:C0007134 | BeFree | After adjusting for patient age, gender, smoking status and body mass index the AG + AA genotypes from rs7105934 (11q13) were associated with a decreased risk of renal cell carcinoma (OR 0.50, 95% CI 0.33-0.75, p = 0.001) and the AC + CC genotypes from rs1049380 (ITPR2) were associated with an increased risk (OR 1.66, 95% CI 1.28-2.16, p <0.001). | 0.000814326 | 2013 | ITPR2 | 12 | 26336611 | G | T |
rs1049380 | 22010048 | 3709 | ITPR2 | umls:C0007134 | BeFree | We identified two common variants in linkage disequilibrium, rs718314 and rs1049380 (r(2) = 0.64, D ' = 0.84), in the inositol 1,4,5-triphosphate receptor, type 2 (ITPR2) gene on 12p11.23 as novel susceptibility loci for RCC (P = 8.89 × 10(-10) and P = 6.07 × 10(-9), respectively, in meta-analysis) with an allelic odds ratio of 1.19 [95% confidence interval (CI): 1.13-1.26] for rs718314 and 1.18 (95% CI: 1.12-1.25) for rs1049380. | 0.000814326 | 2012 | ITPR2 | 12 | 26336611 | G | T |
rs1052133 | 21166493 | 4968 | OGG1 | umls:C0007134 | BeFree | hOGG1 Ser326Cys polymorphism and renal cell carcinoma risk in a Chinese population. | 0.202995792 | 2011 | OGG1;CAMK1 | 3 | 9757089 | C | G |
rs10771279 | 24220910 | 7515 | XRCC1 | umls:C0007134 | BeFree | The 12p11.23 variant rs10771279, located 77 kb from the European-ancestry RCC marker rs718314, was associated with RCC risk in the GWAS (P = 1.2 × 10(-7)) but did not replicate (P = 0.99). | 0.015939126 | 2014 | ITPR2 | 12 | 26377610 | T | A,C |
rs11022095 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11965380 | A | G |
rs11022095 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11965380 | A | G |
rs113488022 | 26014474 | 673 | BRAF | umls:C0007134 | BeFree | Thus, BRAF V600E immunostaining is a helpful marker for pediatric metanephric adenoma, and additional research is required on the possible role of this mutation in the development of renal carcinoma. | 0.000542884 | 2015 | BRAF | 7 | 140753336 | A | T,G,C |
rs113488022 | 26014474 | 673 | BRAF | umls:C1378703 | BeFree | Thus, BRAF V600E immunostaining is a helpful marker for pediatric metanephric adenoma, and additional research is required on the possible role of this mutation in the development of renal carcinoma. | 0.000271442 | 2015 | BRAF | 7 | 140753336 | A | T,G,C |
rs11540654 | 17634539 | 7157 | TP53 | umls:C0007134 | BeFree | Polymorphisms of p53 Arg(72)Pro and p21 Ser(31)Arg did not show significant association with RCC. | 0.150355339 | 2007 | TP53 | 17 | 7676040 | C | T,G,A |
rs11549465 | 18949419 | 3091 | HIF1A | umls:C0007134 | BeFree | In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers. | 0.03690967 | 2008 | HIF1A;LOC105370526 | 14 | 61740839 | C | T |
rs11549467 | 18949419 | 3091 | HIF1A | umls:C0007134 | BeFree | In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers. | 0.03690967 | 2008 | HIF1A;LOC105370526 | 14 | 61740857 | G | A |
rs11614913 | 24681820 | 406938 | MIR146A | umls:C0007134 | BeFree | miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913 and miR-499 rs3746444) to assess their associations with RCC risk in a two-stage case-control study (355 cases and 362 controls in discovery set, meanwhile 647 cases and 660 controls in validation set), as well as RCC survival in 311 patients. | 0.002638474 | 2014 | MIR196A2 | 12 | 53991815 | C | T |
rs11894252 | 21131975 | 2034 | EPAS1 | umls:C0007134 | BeFree | Two correlated variants (r² = 0.99 in controls), rs11894252 (P = 1.8 × 10⁻⁸) and rs7579899 (P = 2.3 × 10⁻⁹), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. | 0.332701686 | 2011 | EPAS1;LOC105374583 | 2 | 46306237 | T | C |
rs12105918 | 23184150 | 9839 | ZEB2 | umls:C0007134 | GWASCAT | Our findings suggest that genetic variation in ZEB2 influences the risk of RCC. | 0.121357209 | 2013 | ZEB2;LOC105373659;LOC105373660 | 2 | 144450626 | T | C |
rs121913243 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116777410 | A | C,G |
rs121913246 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116783360 | A | G |
rs121913668 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116778827 | T | C |
rs121913669 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116782027 | G | A,T |
rs121913670 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116783329 | G | A |
rs121913671 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116783353 | G | A |
rs121913673 | NA | 4233 | MET | umls:C0007134 | CLINVAR | NA | 0.253320515 | NA | MET | 7 | 116782048 | C | G |
rs12953717 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SMAD7 | 18 | 48927559 | C | T |
rs12953717 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SMAD7 | 18 | 48927559 | C | T |
rs132770 | 25569644 | 2547 | XRCC6 | umls:C0007134 | BeFree | Sensitivity analyses were also performed.The rs2267437 polymorphism was associated with a significant increase in risks of overall cancers, breast cancer, renal cell carcinoma and hepatocellular carcinoma, and it could increase the cancer risk in Asian population; the rs5751129 polymorphism could increase the cancer risk in overall cancers; the rs132770 polymorphism was associated with the increased renal cell carcinoma risk; furthermore, the rs132793 polymorphism could decrease breast cancer risk and increase risks in other cancers.Overall, the results provided evidences that the single nucleotide polymorphisms in XRCC6 promoter region might play different roles in various cancers, indicating different cancers have different tumorigenesis mechanisms. | 0.001085767 | 2015 | XRCC6;DESI1 | 22 | 41621260 | A | G |
rs132793 | 25569644 | 2547 | XRCC6 | umls:C0007134 | BeFree | Sensitivity analyses were also performed.The rs2267437 polymorphism was associated with a significant increase in risks of overall cancers, breast cancer, renal cell carcinoma and hepatocellular carcinoma, and it could increase the cancer risk in Asian population; the rs5751129 polymorphism could increase the cancer risk in overall cancers; the rs132770 polymorphism was associated with the increased renal cell carcinoma risk; furthermore, the rs132793 polymorphism could decrease breast cancer risk and increase risks in other cancers.Overall, the results provided evidences that the single nucleotide polymorphisms in XRCC6 promoter region might play different roles in various cancers, indicating different cancers have different tumorigenesis mechanisms. | 0.001085767 | 2015 | NA | 22 | 41667677 | A | G |
rs1472189 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | NA | 11 | 11962338 | C | T |
rs1472189 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | NA | 11 | 11962338 | C | T |
rs149617956 | 23167872 | 4286 | MITF | umls:C0007134 | BeFree | A French and an Australian study have recently identified a rare germline functional variant in the microphthalmia-associated transcription factor (MITF) (E318K) that predisposes to familial and sporadic melanoma and to renal cell carcinoma (RCC), showing a new link between two tumour types with different risk factors and between deregulated sumoylation and cancer. | 0.121085767 | 2013 | MITF | 3 | 69964940 | G | A |
rs17037102 | 19562778 | 27123 | DKK2 | umls:C0007134 | BeFree | To the authors' knowledge, this is the first report documenting that DKK3 polymorphisms are associated with RCC and that the DKK2 rs17037102 polymorphism may be a predictor for survival in patients with RCC after radical nephrectomy. | 0.002909916 | 2009 | DKK2 | 4 | 106924637 | C | T,A |
rs17037102 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106924637 | C | T,A |
rs17037102 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106924637 | C | T,A |
rs17037102 | 19562778 | 27122 | DKK3 | umls:C0007134 | BeFree | To the authors' knowledge, this is the first report documenting that DKK3 polymorphisms are associated with RCC and that the DKK2 rs17037102 polymorphism may be a predictor for survival in patients with RCC after radical nephrectomy. | 0.003181358 | 2009 | DKK2 | 4 | 106924637 | C | T,A |
rs1799793 | 18711149 | 2068 | ERCC2 | umls:C0007134 | BeFree | In individual single nucleotide polymorphism analysis, after adjustment for multiple comparisons, a significantly decreased RCC risk was observed for the heterozygous genotype of XPD Asp312Asn [odds ratio (OR) = 0.62; 95% confidence interval (CI): 0.43-0.90] and for the heterozygous and homozygous variant genotypes combined in a dominant model (OR = 0.64; 95% CI: 0.46-0.89). | 0.005005506 | 2008 | ERCC2 | 19 | 45364001 | C | T |
rs1799864 | 23657965 | 729230 | CCR2 | umls:C0007134 | BeFree | These data suggested that MCP-1 -2518A/G and CCR2 190G/A polymorphisms are new risk factors for RCC and could be used as prognostic markers for this malignancy. | 0.000542884 | 2013 | CCR2 | 3 | 46357717 | G | A |
rs1800645 | 22086884 | 793 | CALB1 | umls:C0007134 | BeFree | Among 154 newly diagnosed cases and 308 matched controls, RCC was associated with higher whole blood lead [OR = 2.0; 95% confidence interval (CI), 1.0-3.9; quartile 4 (Q4) vs. Q1, P(trend) = 0.022] and CALB1 rs1800645 (P(trend) = 0.025, minor 'T' allele frequency = 0.34). | 0.000271442 | 2012 | CALB1 | 8 | 90083245 | A | T |
rs1801270 | 17634539 | 7157 | TP53 | umls:C0007134 | BeFree | Polymorphisms of p53 Arg(72)Pro and p21 Ser(31)Arg did not show significant association with RCC. | 0.150355339 | 2007 | CDKN1A | 6 | 36684194 | C | A,T |
rs1801282 | 11511919 | 54512 | EXOSC4 | umls:C0007134 | BeFree | Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases. | 0.000271442 | 2001 | PPARG | 3 | 12351626 | C | G |
rs1802073 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SFRP4 | 7 | 37907562 | G | T |
rs1802073 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SFRP4 | 7 | 37907562 | G | T |
rs1802074 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SFRP4 | 7 | 37907501 | C | T |
rs1802074 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | SFRP4 | 7 | 37907501 | C | T |
rs1805192 | 11511919 | 54512 | EXOSC4 | umls:C0007134 | BeFree | Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases. | 0.000271442 | 2001 | PPARG | 3 | 12379739 | C | G |
rs1805794 | 18768505 | 55655 | NLRP2 | umls:C0007134 | BeFree | Using the homozygous wild type as the reference group, we observed a significantly increased renal cell carcinoma risk associated with the homozygous variant genotype of NBS1 (rs1805794; odds ratio, 2.13; 95% confidence interval (95% CI), 1.17-3.86). | 0.000542884 | 2008 | NBN | 8 | 89978251 | C | G |
rs1805794 | 25073514 | 55655 | NLRP2 | umls:C0007134 | BeFree | A number of studies have investigated the association between the NBS1 Glu185Gln (rs1805794, 8360 G>C) polymorphism and risk for urinary system cancer including bladder cancer, prostate cancer, and renal cell cancer; however, the findings are conflicting. | 0.000542884 | 2014 | NBN | 8 | 89978251 | C | G |
rs2073664 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK4 | 8 | 42374268 | G | A |
rs2073664 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK4 | 8 | 42374268 | G | A |
rs2243250 | 23572437 | 3565 | IL4 | umls:C0007134 | BeFree | Taken together, our results indicated that IL-4 rs2243250 polymorphism was associated with decreased oral cancer risk in both the homozygote contrasts and the dominant genetic model, as well as increased renal cell cancer risk in both the homozygote contrasts and the recessive genetic model. | 0.008262808 | 2013 | IL4 | 5 | 132673462 | C | T |
rs2267437 | 25569644 | 2547 | XRCC6 | umls:C0007134 | BeFree | Sensitivity analyses were also performed.The rs2267437 polymorphism was associated with a significant increase in risks of overall cancers, breast cancer, renal cell carcinoma and hepatocellular carcinoma, and it could increase the cancer risk in Asian population; the rs5751129 polymorphism could increase the cancer risk in overall cancers; the rs132770 polymorphism was associated with the increased renal cell carcinoma risk; furthermore, the rs132793 polymorphism could decrease breast cancer risk and increase risks in other cancers.Overall, the results provided evidences that the single nucleotide polymorphisms in XRCC6 promoter region might play different roles in various cancers, indicating different cancers have different tumorigenesis mechanisms. | 0.001085767 | 2015 | XRCC6;DESI1 | 22 | 41620695 | C | G |
rs2273535 | 17143471 | 6790 | AURKA | umls:C0007134 | BeFree | Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma. | 0.002909916 | 2007 | AURKA | 20 | 56386485 | A | T |
rs2291599 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11968352 | T | C |
rs2291599 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11968352 | T | C |
rs2292832 | 24681820 | 406938 | MIR146A | umls:C0007134 | BeFree | miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913 and miR-499 rs3746444) to assess their associations with RCC risk in a two-stage case-control study (355 cases and 362 controls in discovery set, meanwhile 647 cases and 660 controls in validation set), as well as RCC survival in 311 patients. | 0.002638474 | 2014 | GPC1;MIR149;PP14571 | 2 | 240456086 | T | C |
rs2504106 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DAAM2 | 6 | 39854343 | A | G |
rs2504106 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DAAM2 | 6 | 39854343 | A | G |
rs25422 | 22010048 | 387119 | CEP85L | umls:C0007134 | GAD | [A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.] | 0.002367032 | 2012 | CEP85L;LOC105377971 | 6 | 118486684 | C | T |
rs2910164 | 24681820 | 406938 | MIR146A | umls:C0007134 | BeFree | miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913 and miR-499 rs3746444) to assess their associations with RCC risk in a two-stage case-control study (355 cases and 362 controls in discovery set, meanwhile 647 cases and 660 controls in validation set), as well as RCC survival in 311 patients. | 0.002638474 | 2014 | LOC285628;MIR146A | 5 | 160485411 | C | G |
rs3118523 | 19753122 | 6256 | RXRA | umls:C0007134 | BeFree | Across RXRA, one haplotype located 3' of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. | 0.002638474 | 2009 | NA | 9 | 134443675 | G | A |
rs3206824 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11964514 | T | C |
rs3206824 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11964514 | T | C |
rs3746444 | 24681820 | 406938 | MIR146A | umls:C0007134 | BeFree | miR-146a rs2910164, miR-149 rs2292832, miR-196a2 rs11614913 and miR-499 rs3746444) to assess their associations with RCC risk in a two-stage case-control study (355 cases and 362 controls in discovery set, meanwhile 647 cases and 660 controls in validation set), as well as RCC survival in 311 patients. | 0.002638474 | 2014 | MYH7B;MIR499A;MIR499B | 20 | 34990448 | A | G |
rs386519031 | 18949419 | 3091 | HIF1A | umls:C0007134 | BeFree | In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers. | 0.03690967 | 2008 | NA | NA | NA | NA | NA |
rs386833395 | 23086583 | 672 | BRCA1 | umls:C0007134 | BeFree | We report the first tumor study of renal cell carcinoma in a carrier of the deleterious BRCA1 mutation-c.68_69delAG. | 0.000542884 | 2013 | BRCA1;NBR2 | 17 | 43124028 | CT | - |
rs419558 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106922935 | C | T |
rs419558 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106922935 | C | T |
rs447372 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106932839 | G | A |
rs447372 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK2 | 4 | 106932839 | G | A |
rs4765623 | 21131975 | 949 | SCARB1 | umls:C0007134 | GWASCAT | Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. | 0.242367032 | 2011 | SCARB1 | 12 | 124836304 | C | T |
rs4953345 | 25826619 | 2034 | EPAS1 | umls:C0007134 | GWASCAT | Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer. | 0.332701686 | 2015 | EPAS1;LOC105374583 | 2 | 46325462 | T | A |
rs5751129 | 25569644 | 2547 | XRCC6 | umls:C0007134 | BeFree | Sensitivity analyses were also performed.The rs2267437 polymorphism was associated with a significant increase in risks of overall cancers, breast cancer, renal cell carcinoma and hepatocellular carcinoma, and it could increase the cancer risk in Asian population; the rs5751129 polymorphism could increase the cancer risk in overall cancers; the rs132770 polymorphism was associated with the increased renal cell carcinoma risk; furthermore, the rs132793 polymorphism could decrease breast cancer risk and increase risks in other cancers.Overall, the results provided evidences that the single nucleotide polymorphisms in XRCC6 promoter region might play different roles in various cancers, indicating different cancers have different tumorigenesis mechanisms. | 0.001085767 | 2015 | XRCC6;DESI1 | 22 | 41619761 | C | T |
rs6937133 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DAAM2 | 6 | 39832238 | A | G |
rs6937133 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DAAM2 | 6 | 39832238 | A | G |
rs701848 | 23209702 | 5728 | PTEN | umls:C0007134 | BeFree | Another variant (rs701848) in the 3'UTR region of PTEN was associated with increased RCC risk (P = 0.014, OR = 1.45, 95%CI = 1.08-1.96, CC vs. TT); however, the association was not significant after adjusting for multiple comparisons. | 0.135240471 | 2012 | PTEN | 10 | 87966988 | T | C |
rs7105934 | 23911636 | 3709 | ITPR2 | umls:C0007134 | BeFree | After adjusting for patient age, gender, smoking status and body mass index the AG + AA genotypes from rs7105934 (11q13) were associated with a decreased risk of renal cell carcinoma (OR 0.50, 95% CI 0.33-0.75, p = 0.001) and the AC + CC genotypes from rs1049380 (ITPR2) were associated with an increased risk (OR 1.66, 95% CI 1.28-2.16, p <0.001). | 0.000814326 | 2013 | LOC102724265 | 11 | 69424973 | G | A |
rs7105934 | 21131975 | 102724265 | LOC102724265 | umls:C0007134 | GWASCAT | Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. | 0.12 | 2011 | LOC102724265 | 11 | 69424973 | G | A |
rs7121 | 22931242 | 2778 | GNAS | umls:C0007134 | BeFree | GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study. | 0.000542884 | 2012 | GNAS | 20 | 58903752 | C | T |
rs718314 | 22010048 | 8082 | SSPN | umls:C0007134 | GAD | [A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.] | 0.002367032 | 2012 | LOC105369705 | 12 | 26300350 | A | G |
rs718314 | 22010048 | 3709 | ITPR2 | umls:C0007134 | BeFree | We identified two common variants in linkage disequilibrium, rs718314 and rs1049380 (r(2) = 0.64, D ' = 0.84), in the inositol 1,4,5-triphosphate receptor, type 2 (ITPR2) gene on 12p11.23 as novel susceptibility loci for RCC (P = 8.89 × 10(-10) and P = 6.07 × 10(-9), respectively, in meta-analysis) with an allelic odds ratio of 1.19 [95% confidence interval (CI): 1.13-1.26] for rs718314 and 1.18 (95% CI: 1.12-1.25) for rs1049380. | 0.000814326 | 2012 | LOC105369705 | 12 | 26300350 | A | G |
rs718314 | 25053674 | 3709 | ITPR2 | umls:C0007134 | BeFree | A variant (rs718314) in the inositol 1,4,5-trisphosphate receptor, type 2 gene (ITPR2) was found to interact with the American/Western dietary pattern in relation to RCC risk (additive Pinteraction = 0.03). | 0.000814326 | 2014 | LOC105369705 | 12 | 26300350 | A | G |
rs718314 | 24220910 | 7515 | XRCC1 | umls:C0007134 | BeFree | The 12p11.23 variant rs10771279, located 77 kb from the European-ancestry RCC marker rs718314, was associated with RCC risk in the GWAS (P = 1.2 × 10(-7)) but did not replicate (P = 0.99). | 0.015939126 | 2014 | LOC105369705 | 12 | 26300350 | A | G |
rs72858496 | 25826619 | 9839 | ZEB2 | umls:C0007134 | GWASCAT | Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer. | 0.121357209 | 2015 | ZEB2;LOC105373659 | 2 | 144452349 | C | T |
rs7396187 | 19562778 | 6424 | SFRP4 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11967604 | C | G |
rs7396187 | 19562778 | 23500 | DAAM2 | umls:C0007134 | BeFree | including Dickkopf 2 (DKK2) (reference SNP identification number 17037102 [rs17037102], rs419558, and rs447372), DKK3 (rs3206824, rs11022095, rs1472189, rs7396187, and rs2291599), DKK4 (rs2073664), secreted frizzled-related protein 4 (sFRP4) (rs1802073 and rs1802074), mothers against decapentaplegic homolog (SMAD) family member 7 or SMAD7 (rs12953717), and disheveled associated activator of morphogenesis 2 or DAAM2 (rs6937133 and rs2504106) using polymerase chain reaction-restriction fragment length polymorphism analysis and direct sequencing in the patients with RCC and in the healthy, age-matched control group. | 0.002638474 | 2009 | DKK3 | 11 | 11967604 | C | G |
rs748964 | 19753122 | 6256 | RXRA | umls:C0007134 | BeFree | Across RXRA, one haplotype located 3' of the coding sequence (rs748964, rs3118523), increased RCC risk 35% among individuals with the variant haplotype compared to those with the most common haplotype. | 0.002638474 | 2009 | NA | 9 | 134442243 | C | G |
rs7579899 | 21131975 | 2034 | EPAS1 | umls:C0007134 | GWASCAT | Two correlated variants (r² = 0.99 in controls), rs11894252 (P = 1.8 × 10⁻⁸) and rs7579899 (P = 2.3 × 10⁻⁹), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. | 0.332701686 | 2011 | EPAS1;LOC105374583 | 2 | 46310465 | A | G |
rs7579899 | 21131975 | 2034 | EPAS1 | umls:C0007134 | BeFree | Two correlated variants (r² = 0.99 in controls), rs11894252 (P = 1.8 × 10⁻⁸) and rs7579899 (P = 2.3 × 10⁻⁹), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. | 0.332701686 | 2011 | EPAS1;LOC105374583 | 2 | 46310465 | A | G |
rs7579899 | 21131975 | 2034 | EPAS1 | umls:C0007134 | GAD | [Two correlated variants (rA2 = 0.99 in controls), rs11894252 (P = 1.8 A 10a>>a,) and rs7579899 (P = 2.3 A 10a>>a1), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC.] | 0.332701686 | 2011 | EPAS1;LOC105374583 | 2 | 46310465 | A | G |
rs8081059 | 25900876 | 201266 | SLC39A11 | umls:C0007134 | BeFree | A ZIP11 variant, rs8081059, was significantly associated with increased risk of renal cell carcinoma (odds ratios (OR) = 1.28, 95 % confidence intervals (CI) (1.13-1.45), p = 0.049). | 0.000271442 | 2015 | SLC39A11 | 17 | 73072580 | C | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:122) | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHR | POS | SNPID | REF | ALT | ORI_SNPID | PMID | P_VALUE | P_VALUE_TEXT | OR/BETA | CI95_TEXT | GWAS_INITIAL_SAMPLE_SIZE | SUB_POPULATION | SUPER_POPULATION | GWAS_TRAIT | HPO_ID | HPO_TERM | DO_ID | DO_TERM | MESH_ID | MESH_TERM | EFO_ID | EFO_TERM | DOLITE_TERM | RISK_ALLELE | PUBLICATION_TYPE | AA | GENE_SYMBOL | TYPE | REFGENE |
1 | 48063350 | rs10890492 | G | A | rs10890492 | 22010048 | 1.41E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
1 | 64804379 | rs1390473 | A | G | rs1390473 | 24220910 | 1.60E-04 | NA | 1.54 | [1.23-1.92] | 255 African American cases; 375 African American controls | African American(630) | ALL(630) | AFR(630) | ALL(630) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | rs1390473-T | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
1 | 85807695 | rs233072 | A | G | rs233072 | 24220910 | 2.50E-04 | NA | 1.43 | [1.18-1.73] | 255 African American cases; 375 African American controls | African American(630) | ALL(630) | AFR(630) | ALL(630) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | rs233072-G | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
2 | 15256606 | rs1990851 | A | G | rs1990851 | 23184150 | 1.74E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 46525391 | rs1867787 | G | C | rs1867787 | 21131975 | 1.90E-07 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46526096 | rs10211665 | T | C | rs10211665 | 21131975 | 1.90E-07 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46527816 | rs11125068 | A | G | rs11125068 | 21131975 | 2.30E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46528961 | rs2346417 | T | A | rs2346417 | 21131975 | 8.20E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46529302 | rs1867783 | G | C | rs1867783 | 21131975 | 1.30E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46533376 | rs11894252 | T | C | rs11894252 | 21131975 | 9.10E-09 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46533376 | rs11894252 | T | C | rs11894252 | 22010048 | 1.80E-08 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 46533552 | rs11684885 | T | G | rs11684885 | 21131975 | 9.00E-09 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46534220 | rs1867784 | T | C | rs1867784 | 21131975 | 6.20E-09 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46534338 | rs1867785 | A | G | rs1867785 | 21131975 | 8.80E-09 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46535924 | rs2121266 | C | A | rs2121266 | 21131975 | 1.40E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46537056 | rs4952818 | C | T | rs4952818 | 21131975 | 2.80E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46537604 | rs7579899 | A | G | rs7579899 | 21131975 | 2.00E-09 | NA | 1.15 | [1.10-1.21] | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46538794 | rs17034950 | G | A | rs17034950 | 21131975 | 8.20E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46541176 | rs11689011 | T | C | rs11689011 | 21131975 | 2.60E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46546316 | rs2044456 | A | G | rs2044456 | 21131975 | 4.40E-07 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46548064 | rs4953340 | C | G | rs4953340 | 21131975 | 5.20E-08 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46548109 | rs9973653 | G | T | rs9973653 | 21131975 | 1.60E-07 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46549040 | rs2034327 | G | C | rs2034327 | 21131975 | 7.20E-07 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46549389 | rs2121267 | T | C | rs2121267 | 21131975 | 2.20E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46550492 | rs895436 | G | C | rs895436 | 21131975 | 6.70E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46550718 | rs4952819 | G | C | rs4952819 | 21131975 | 6.80E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46552177 | rs4953343 | G | C | rs4953343 | 21131975 | 3.20E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46552601 | rs4953345 | T | A | rs4953345 | 21131975 | 9.10E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46553966 | rs4952820 | A | G | rs4952820 | 21131975 | 4.00E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46554533 | rs11125071 | C | G | rs11125071 | 21131975 | 4.00E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46554646 | rs1868089 | C | T | rs1868089 | 21131975 | 4.20E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46555221 | rs12613519 | A | G | rs12613519 | 21131975 | 8.70E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46555263 | rs12613526 | A | G | rs12613526 | 21131975 | 8.60E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46555670 | rs10208823 | T | C | rs10208823 | 21131975 | 3.50E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46556633 | rs12712973 | A | C | rs12712973 | 21131975 | 8.50E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46556761 | rs12620992 | G | C | rs12620992 | 21131975 | 5.10E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46556824 | rs6706717 | A | G | rs6706717 | 21131975 | 5.20E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G,A |
2 | 46557600 | rs11900910 | C | T | rs11900910 | 21131975 | 9.00E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46557644 | rs9679290 | G | C | rs9679290 | 21131975 | 7.30E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46557962 | rs35366004 | G | T | rs35366004 | 21131975 | 7.70E-06 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46558208 | rs4953346 | T | G | rs4953346 | 21131975 | 1.40E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46558225 | rs4953347 | A | G | rs4953347 | 21131975 | 1.30E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46558432 | rs4953348 | A | G | rs4953348 | 21131975 | 1.40E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46558541 | rs6758592 | T | C | rs6758592 | 21131975 | 2.20E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46559776 | rs12617313 | A | T | rs12617313 | 21131975 | 1.90E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46560084 | rs11125072 | T | A | rs11125072 | 21131975 | 1.70E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46560644 | rs4953349 | T | A,G | rs4953349 | 21131975 | 2.30E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46561202 | rs6726454 | A | G | rs6726454 | 21131975 | 1.70E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46561309 | rs6726570 | A | G | rs6726570 | 21131975 | 1.70E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46561816 | rs4145837 | G | A | rs4145837 | 21131975 | 1.80E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46563392 | rs6706003 | C | G | rs6706003 | 21131975 | 3.40E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46564583 | rs4953351 | C | A | rs4953351 | 21131975 | 7.20E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46565091 | rs12614710 | T | G | rs12614710 | 21131975 | 2.70E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46565522 | rs4953352 | T | C | rs4953352 | 21131975 | 5.30E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46567227 | rs4035887 | A | G | rs4035887 | 21131975 | 9.30E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46571310 | rs2346175 | T | C | rs2346175 | 21131975 | 2.00E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46576172 | rs6715787 | C | G | rs6715787 | 21131975 | 3.50E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46576488 | rs17035010 | C | T | rs17035010 | 21131975 | 7.50E-05 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46576573 | rs17035013 | T | C | rs17035013 | 21131975 | 1.80E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46579348 | rs6743087 | T | C | rs6743087 | 21131975 | 3.50E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46579409 | rs6756667 | A | G | rs6756667 | 21131975 | 9.30E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46579730 | rs1562451 | C | T | rs1562451 | 21131975 | 3.50E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46580474 | rs1562453 | T | C | rs1562453 | 21131975 | 6.30E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46581453 | rs4953358 | C | G | rs4953358 | 21131975 | 7.50E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46581544 | rs7599883 | T | A | rs7599883 | 21131975 | 3.50E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46582382 | rs7589621 | G | A | rs7589621 | 21131975 | 3.40E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
2 | 46582891 | rs6712143 | A | G | rs6712143 | 21131975 | 3.40E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46583593 | rs2278753 | G | A | rs2278753 | 21131975 | 6.60E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46584573 | rs10176396 | C | T | rs10176396 | 21131975 | 3.20E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
2 | 46584852 | rs6707241 | C | T | rs6707241 | 21131975 | 8.40E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46585888 | rs6740096 | A | T | rs6740096 | 21131975 | 8.40E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46587097 | rs7583554 | T | C | rs7583554 | 21131975 | 6.80E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 46589179 | rs4953360 | A | G | rs4953360 | 21131975 | 6.70E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46589295 | rs6755594 | A | G | rs6755594 | 21131975 | 9.00E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | A |
2 | 46592006 | rs3768729 | T | C | rs3768729 | 21131975 | 6.70E-04 | NA | NA | NA | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | T |
2 | 128404860 | rs3771295 | A | G | rs3771295 | 22010048 | 1.00E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145152235 | rs11888238 | T | C | rs11888238 | 23184150 | 5.03E-05 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145155731 | rs10185359 | T | C | rs10185359 | 23184150 | 4.63E-04 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145169563 | rs7560525 | A | G | rs7560525 | 23184150 | 2.07E-05 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145171259 | rs72858437 | T | C | rs72858437 | 23184150 | 4.80E-04 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145182957 | rs10210063 | C | G | rs10210063 | 23184150 | 1.70E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145184316 | rs10192562 | A | G | rs10192562 | 23184150 | 2.38E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145193326 | rs10164806 | C | T | rs10164806 | 23184150 | 1.92E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145198623 | rs13401103 | G | A | rs13401103 | 23184150 | 6.10E-07 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145198889 | rs72858474 | G | A | rs72858474 | 23184150 | 4.89E-07 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145204758 | rs16823732 | G | A | rs16823732 | 23184150 | 1.58E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145208193 | rs12105918 | T | C | rs12105918 | 23184150 | 2.00E-08 | NA | 1.45 | [1.20-1.75] | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145208336 | rs12105521 | G | A,T | rs12105521 | 23184150 | 7.28E-07 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145209916 | rs72858496 | C | T | rs72858496 | 23184150 | 5.76E-07 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145213638 | rs731108 | G | C | rs731108 | 23184150 | 1.34E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145216048 | rs13389578 | T | C | rs13389578 | 23184150 | 3.58E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
2 | 145216132 | rs13401515 | A | T | rs13401515 | 23184150 | 2.43E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
3 | 2561556 | rs17620999 | A | G | rs17620999 | 23184150 | 2.11E-05 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
3 | 57473750 | rs10510793 | G | A | rs10510793 | 22010048 | 4.49E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
3 | 194328524 | rs789997 | A | G | rs789997 | 23184150 | 6.44E-06 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
5 | 32000483 | rs10054504 | T | C | rs10054504 | 23184150 | 8.00E-07 | NA | 1.37 | [1.19-1.58] | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
6 | 85777822 | rs7765284 | C | A | rs7765284 | 23184150 | 9.37E-07 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
6 | 118807847 | rs25422 | C | T | rs25422 | 22010048 | 5.00E-06 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
7 | 129670412 | rs4507692 | T | C | rs4507692 | 22010048 | 2.10E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
8 | 128889371 | rs6470588 | A | C | rs35252396 | 24220699 | 5.00E-11 | (rs35252396-CG, rs6470588-C, rs6470589-G) | 1.27 | [1.18-1.37] | 1,505 European ancestry cases; 67,725 European ancestry controls | European(69230) | ALL(69230) | EUR(69230) | ALL(69230) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | NA | PVT1 |
10 | 31388250 | rs7080444 | C | T | rs7080444 | 22010048 | 8.36E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
10 | 31415106 | rs793108 | C | T | rs793108 | 22010048 | 1.29E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
10 | 31418463 | rs1340991 | A | G | rs1340991 | 22010048 | 6.45E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
10 | 52036514 | rs10508925 | G | A | rs10508925 | 22010048 | 2.78E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
11 | 69234494 | rs4980785 | C | T | rs4980785 | 22010048 | 2.00E-06 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
11 | 69239741 | rs7105934 | G | A | rs7105934 | 21131975 | 8.00E-14 | NA | 1.45 | [1.32-1.61] | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | G |
11 | 69239741 | rs7105934 | G | A | rs7105934 | 22010048 | 7.80E-14 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
11 | 113864109 | rs897685 | C | T | rs897685 | 22010048 | 4.32E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
11 | 127659737 | rs371808590 | GCA | G | rs6590279 | 22010048 | 3.72E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
11 | 127659737 | rs6590279 | G | A | rs6590279 | 22010048 | 3.72E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
12 | 26453283 | rs718314 | A | G | rs718314 | 22010048 | 9.00E-10 | NA | 1.19 | [1.13-1.26] | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
12 | 26489544 | rs1049380 | G | T | rs1049380 | 22010048 | 6.07E-09 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
12 | 26530543 | rs10771279 | T | C | rs10771279 | 24220910 | 7.60E-05 | NA | 1.54 | [1.23-1.89] | 255 African American cases; 375 African American controls | African American(630) | ALL(630) | AFR(630) | ALL(630) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | rs10771279-T | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
12 | 125320850 | rs4765623 | C | T | rs4765623 | 21131975 | 3.00E-08 | NA | 1.15 | [1.09-1.20] | 3,772 European descent cases; 8,505 European descent controls | European(12277) | ALL(12277) | EUR(12277) | ALL(12277) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural | C |
12 | 129853660 | rs11060283 | C | T | rs11060283 | 22010048 | 8.21E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
14 | 52884355 | rs10143866 | T | C | rs10143866 | 22010048 | 5.19E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
16 | 57341599 | rs1645893 | A | G | rs1645893 | 24220910 | 9.50E-06 | NA | 1.49 | [1.25-1.79] | 255 African American cases; 375 African American controls | African American(630) | ALL(630) | AFR(630) | ALL(630) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | rs1645893-T | Multicenter Study | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't |
17 | 63549488 | rs3923086 | A | C | rs3923086 | 22010048 | 1.66E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
20 | 43871071 | rs6017525 | A | G | rs6017525 | 22010048 | 2.74E-04 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
21 | 17758842 | rs1449522 | T | C | rs1449522 | 22010048 | 2.05E-05 | NA | NA | NA | 894 European ancestry cases; 1,516 European ancestry controls | European(2410) | ALL(2410) | EUR(2410) | ALL(2410) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Research Support, N.I.H., Extramural | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
21 | 39257377 | rs2836034 | A | G | rs2836034 | 23184150 | 4.56E-05 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
22 | 30221120 | rs11549795 | C | T | rs11549795 | 23184150 | 1.45E-05 | NA | NA | NA | 2,215 European ancestry cases; 8,566 European ancestry controls | European(10781) | ALL(10781) | EUR(10781) | ALL(10781) | Renal cell carcinoma | HPOID:0005584 | Renal cell carcinoma | DOID:4450 | renal cell carcinoma | D002292 | Carcinoma, Renal Cell | EFOID:0000681 | renal cell carcinoma | Renal Cell cancer | NA | Meta-Analysis | Research Support, Non-U.S. Gov't | Research Support, N.I.H., Intramural |
Mapped by lexical matching(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001978 | Extramedullary hematopoiesis | MP:0000240 | extramedullary hematopoiesis;HP:0001919 | Acute kidney injury |
Mapped by homologous gene(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002716 | Lymphadenopathy | MP:0002420 | abnormal adaptive immunity;HP:0001894 | Thrombocytosis |
Chemical(Total Drugs:24) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0007134 | acetaminophen | D000082 | 103-90-2 | carcinoma, renal cell | MESH:D002292 | marker/mechanism | 10507783 | ||
C0007134 | celecoxib | D000068579 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 16369983 | ||
C0007134 | cyclophosphamide | D003520 | 50-18-0 | carcinoma, renal cell | MESH:D002292 | marker/mechanism | 8996475 | ||
C0007134 | cyclophosphamide | D003520 | 50-18-0 | carcinoma, renal cell | MESH:D002292 | therapeutic | 16201981 | ||
C0007134 | diethylstilbestrol | D004054 | 56-53-1 | carcinoma, renal cell | MESH:D002292 | marker/mechanism | 2650911 | ||
C0007134 | everolimus | D000068338 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 18653228 | ||
C0007134 | fluorouracil | D005472 | 51-21-8 | carcinoma, renal cell | MESH:D002292 | therapeutic | 15895229 | ||
C0007134 | folic acid | D005492 | 59-30-3 | carcinoma, renal cell | MESH:D002292 | therapeutic | 10663624 | ||
C0007134 | gemcitabine | C056507 | 103882-84-4 | carcinoma, renal cell | MESH:D002292 | therapeutic | 15895229 | ||
C0007134 | hydroxyurea | D006918 | 127-07-1 | carcinoma, renal cell | MESH:D002292 | therapeutic | 4883783 | ||
C0007134 | ifosfamide | D007069 | 3778-73-2 | carcinoma, renal cell | MESH:D002292 | therapeutic | 6495457 | ||
C0007134 | indomethacin | D007213 | 53-86-1 | carcinoma, renal cell | MESH:D002292 | therapeutic | 17341418 | ||
C0007134 | medroxyprogesterone acetate | D017258 | 71-58-9 | carcinoma, renal cell | MESH:D002292 | therapeutic | 1152883 | ||
C0007134 | pazopanib | C516667 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 19956806 | ||
C0007134 | peginterferon alfa-2b | C417083 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 18813777 | ||
C0007134 | sorafenib | C471405 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 18695262 | ||
C0007134 | streptozocin | D013311 | 18883-66-4 | carcinoma, renal cell | MESH:D002292 | marker/mechanism | 128413 | ||
C0007134 | temsirolimus | C401859 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 19232474 | ||
C0007134 | thalidomide | D013792 | 50-35-1 | carcinoma, renal cell | MESH:D002292 | therapeutic | 11592764 | ||
C0007134 | toremifene | D017312 | 89778-26-7 | carcinoma, renal cell | MESH:D002292 | marker/mechanism | 7586193 | ||
C0007134 | vinblastine | D014747 | 865-21-4 | carcinoma, renal cell | MESH:D002292 | therapeutic | 1485588 | ||
C0007134 | vincristine | D014750 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 16201981 | ||
C0007134 | vindesine | D014751 | 53643-48-4 | carcinoma, renal cell | MESH:D002292 | therapeutic | 2930717 | ||
C0007134 | zoledronic acid | C088658 | - | carcinoma, renal cell | MESH:D002292 | therapeutic | 17070308 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |